Live SpaceX Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow BURZYNSKI RESEARCH INSTITUTE INC

Get SEC filing alerts via email and in your feed for BURZYNSKI RESEARCH INSTITUTE INC

BZYR

BURZYNSKI RESEARCH INSTITUTE INC

About BURZYNSKI RESEARCH INSTITUTE INC

Burzynski Research Institute, Inc. focuses on the research, development, and potential commercialization of Antineoplastons—peptide- and amino acid-based compounds intended for cancer treatment. The company conducts clinical trials primarily targeting brain tumors and other cancers, aiming to demonstrate safety and efficacy for regulatory approval. Its business model centers on proprietary formulations, intellectual property licensing, and eventual production and marketing of Antineoplastons in the U.S. and Canada upon regulatory clearance.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from BURZYNSKI RESEARCH INSTITUTE INC

1
1
BURZYNSKI RESEARCH INSTITUTE INC Burzynski Research Institute Reports Decreased Net Loss and Increased Current Assets

Via official filing (AI summary) | 5 months ago | 0 comments

2
1
BURZYNSKI RESEARCH INSTITUTE INC Burzynski Research Institute Reports $665,318 Net Loss for Six Months Ending August 31, 2025

Via official filing (AI summary) | 8 months ago | 0 comments

3
1
BURZYNSKI RESEARCH INSTITUTE INC Burzynski Research Institute Reports Decrease in Net Loss and Increased Total Assets

Via official filing (AI summary) | 11 months ago | 0 comments

4
1
BURZYNSKI RESEARCH INSTITUTE INC Burzynski Research Institute Reports $1.39 Million Net Loss for Fiscal Year Ending February 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

5
1
BURZYNSKI RESEARCH INSTITUTE INC Burzynski Research Institute Reports Q3 Net Loss of $352,000, Faces Financial Challenges

Via official filing (AI summary) | over 1 year ago | 0 comments

6
1
BURZYNSKI RESEARCH INSTITUTE INC Burzynski Research Institute Reports Significant Decline in Assets and Increase in Liabilities, Operating Losses

Via official filing (AI summary) | over 1 year ago | 0 comments